Skip to content

Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02753907
Enrollment
150
Registered
2016-04-28
Start date
2015-06-30
Completion date
Unknown
Last updated
2016-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Brief summary

Self-reported healthy participants (n=150) aged 30-65 years with 18.5 kg/m\^2 ≤ BMI \< 30 kg/m\^2 were randomly assigned into three groups: a low linoleic acid (LA, 18:2n-6) group (n=50) replaced 10 mL soy oil with one apple; a medium LA group (control group, n=50) maintained usual food intake; a high LA group (n=50) reduced 1/3 cup of cooked refined rice and consumed 9.9g of soy oil capsules daily as a supplement. Plasma fatty acids and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity were measured at baseline and 8 week alongside other cardiovascular disease risk factors.

Interventions

DIETARY_SUPPLEMENTLow LA

Individuals who replaced 10 mL soy oil with one apple

DIETARY_SUPPLEMENTHigh LA

Individuals who reduced 1/3 cup of cooked refined rice and consumed 9.9g (9 of 1.1g capsules, 3 capsules at every 3 meals a day) of soy oil as a supplement

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 30 to 65 years at beginning of study * Subjects with BMI 18.5 to 30 kg/m\^2

Exclusion criteria

* Use of any medication or supplements that alter lipid metabolism. * Presence of dyslipidemia, diabetes mellitus, hypertension, liver disease, renal disease, chronic disease of the gastrointestinal tract, cerebrovascular disease, pancreatitis or cancer. * Women who pregnant or lactating. * Drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Change in Lp-PLA2 activity (nmol/mL/min)At baseline and end of each 8-week diet period

Secondary

MeasureTime frameDescription
Change in total cholesterol (mg/dL)At baseline and end of each 8-week diet period
Change in LDL cholesterol (mg/dL)At baseline and end of each 8-week diet periodLipids and lipoproteins, such as total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, Apo A-I, Apo B
Change in HDL cholesterol (mg/dL)At baseline and end of each 8-week diet period
Change in triglyceride (mg/dL)At baseline and end of each 8-week diet period

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026